Inactivated Vaccine Market - Size, Share, Outlook, and Forecast till 2026

A vaccine that consists of virus particles, bacteria or other pathogens, which were grown in culture and then killed using heat or formaldehyde is called as inactivated vaccine or killed vaccine. The infectivity is reduced, as pathogens for inactivated vaccines are grown under controlled conditions and are killed. Inactivated vaccines are classified into whole virus vaccines, split virus vaccines, and subunit vaccines based on the method of inactivation of virus.

Increasing demand for inactivated vaccines from governments of industrialized and emerging economies is one of the major factors that is expected to drive growth of the global inactivated vaccines market over the forecast period. Moreover, advantages of inactivated vaccines such as safety, stability, and lack of chances of pathogen reactivation over live attenuated vaccines are expected to fuel growth of the global inactivated vaccines market during the forecast period. Rising prevalence of infectious diseases and increasing awareness among people about immunization are other factors propelling the market growth.

However, stringent government regulations and lack of supply of vaccines in remote areas are major factors that are expected to restrain growth of the global inactivated vaccines market.

Key Developments in Inactivated Vaccine Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the inactivated vaccine market. In 2017, Seqirus, a leading innovator in influenza vaccines and pandemic preparedness, announced its next major advancement in the use of cell-based influenza vaccine technology at its state-of-the art manufacturing facility in Holly Springs, North Carolina.

Moreover, in August 2017, Seqirus launched a new influenza vaccine called FLUAD 1, which is an adjuvanted trivalent influenza vaccine (aTIV) developed to address the burden of influenza in adults aged 65 years and over.

In March 2018, Sanofi completed the acquisition of Bioverativ Inc, a global biotechnology company. Also, Fluzone QIV HD (Quadrivalent Inactivated Influenza Vaccine - High Dose) by Sanofi is currently in phase 111 clinical trial.

Some of the major players operating in the global inactivated vaccine market include Emergent BioSolutions, GlaxoSmithKline plc, Merck & Co., Inc., Seqirus, Sanofi, Valneva SE, Pfizer Inc., and Bharat Biotech among others.

Global Varicella Freeze-Dried Attenuated Live Vaccine Market Research Report 2018

Published Date : Jul 2018

Varicella Freeze-Dried Attenuated Live Vaccine Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main c...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Varicella Vaccine Market 2018, Forecast to 2023

Published Date : Jun 2018

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c...

Global Varicella Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Published Date : Jun 2018

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) 23-Valent Pneumococcal Polysaccharide Vaccine Market 2018, Forecast to 2023

Published Date : Jun 2018

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for...

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published Date : Jun 2018

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) All Vaccine Market 2018, Forecast to 2023

Published Date : Jun 2018

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The ag...

Global All Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published Date : Jun 2018

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The ag...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vaccine Adjuvants Market 2018, Forecast to 2023

Published Date : Jun 2018

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been ...

Global Vaccine Adjuvants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published Date : Jun 2018

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been ...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Newcastle Disease Vaccine Market 2018, Forecast to 2023

Published Date : Jun 2018

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens. ...

 

Select Licence :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.